Home › Funds › Octagon Capital Advisors LP › MIRM
Octagon Capital Advisors LP position in MIRM
MIRUM PHARMACEUTICALS INC · Health Care
Octagon Capital Advisors LP reported holding 169,450 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$14.5M, representing 1.93% of its reported portfolio and ranking #13 among its reported holdings. Octagon Capital Advisors LP has disclosed MIRM holdings in 4 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Octagon Capital Advisors LP's MIRM position evolved
Octagon Capital Advisors LP first disclosed a stake in MIRM in Q4 2023 at 25,000 shares (US$738K). The position peaked in Q2 2026 at 338,900 shares, worth US$39.7M. Across 4 filings, Octagon Capital Advisors LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 169,450 shares valued at US$14.5M — a reduction of -169,450 shares quarter over quarter.. Notable position changes include a 50% trim in Q3 2026 (shares rose 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 25.00K | $738.00K | New |
| Q1 2026 | 338.90K | $31.31M | New |
| Q2 2026 | 338.90K | $39.68M | Hold |
| Q3 2026 | 169.45K | $14.48M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MIRM and 13F data
MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 39 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$656.5M), EVENTIDE ASSET MANAGEMENT, LLC (US$106.7M), TANG CAPITAL MANAGEMENT LLC (US$105.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MIRM
- Frazier Life Sciences Management, L.P. 7.68M sh · $656.46M · Q3 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.25M sh · $106.72M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 1.24M sh · $105.66M · Q3 2026
- Novo Holdings A/S 1.12M sh · $96.17M · Q3 2026
- TCG Crossover Management, LLC 1.12M sh · $95.65M · Q3 2026
- Rock Springs Capital Management LP 779.79K sh · $66.66M · Q3 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 17.15M sh · $47.20M · Q3 2026
- EMERALD ADVISERS, LLC 469.77K sh · $40.16M · Q3 2026
More on Octagon Capital Advisors LP
FAQ
How long has Octagon Capital Advisors LP held MIRM?
Octagon Capital Advisors LP has disclosed MIRM holdings in 4 of the last 12 reported quarters, going back to Q4 2023.
What is Octagon Capital Advisors LP's current position in MIRM?
As of Q3 2026, Octagon Capital Advisors LP holds 169.45K shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $14.48M, representing 1.93% of its reported portfolio and ranking #13.
Has Octagon Capital Advisors LP been buying or selling MIRM?
In the latest 13F filing (Q3 2026), Octagon Capital Advisors LP reduced its position in MIRM. The position peaked in Q2 2026 at 338.90K shares.
Which other funds hold MIRM?
Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.